Global, regional, and national health inequalities of Alzheimer’s disease and Parkinson’s disease in 204 countries, 1990–2019
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Global, regional, and national health inequalities of Alzheimer’s disease and Parkinson’s disease in 204 countries, 1990–2019 ; volume:23 ; number:1 ; day:19 ; month:6 ; year:2024 ; pages:1-12 ; date:12.2024
International journal for equity in health ; 23, Heft 1 (19.6.2024), 1-12, 12.2024
- Urheber
-
Ji, Zixiang
Chen, Qi
Yang, Jing
Hou, Jiazhe
Wu, Hengjing
Zhang, Lijuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12939-024-02212-5
- URN
-
urn:nbn:de:101:1-2409102119370.286125873962
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ji, Zixiang
- Chen, Qi
- Yang, Jing
- Hou, Jiazhe
- Wu, Hengjing
- Zhang, Lijuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Numerische Analyse der Vlasov-Gleichung mittels Wavelets
Die Frauenbewegung in China am Ende der Qingsynastie
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Numerische Analyse der Vlasov-Gleichung mittels Wavelets
Die Frauenbewegung in China am Ende der Qingsynastie
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Numerische Analyse der Vlasov-Gleichung mittels Wavelets
Die Frauenbewegung in China am Ende der Qingsynastie
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia